November 2017 - Volume 23 - Issue 11 - Contributor Index

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?

Meijer, Berrie; Seinen, Margien L.; van Egmond, Remco; More

Inflammatory Bowel Diseases. 23(11):2011-2017, November 2017.

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma

Nissen, Loes H. C.; Pierik, Marieke; Derikx, Lauranne A. A. P.; More

Inflammatory Bowel Diseases. 23(11):2018-2026, November 2017.

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma

Nissen, Loes H. C.; Pierik, Marieke; Derikx, Lauranne A. A. P.; More

Inflammatory Bowel Diseases. 23(11):2018-2026, November 2017.

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?

Meijer, Berrie; Seinen, Margien L.; van Egmond, Remco; More

Inflammatory Bowel Diseases. 23(11):2011-2017, November 2017.

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma

Nissen, Loes H. C.; Pierik, Marieke; Derikx, Lauranne A. A. P.; More

Inflammatory Bowel Diseases. 23(11):2018-2026, November 2017.

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Gonczi, Lorant; Gecse, Krisztina B.; Vegh, Zsuzsanna; More

Inflammatory Bowel Diseases. 23(11):1908-1915, November 2017.

Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma

Nissen, Loes H. C.; Pierik, Marieke; Derikx, Lauranne A. A. P.; More

Inflammatory Bowel Diseases. 23(11):2018-2026, November 2017.

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Gonczi, Lorant; Gecse, Krisztina B.; Vegh, Zsuzsanna; More

Inflammatory Bowel Diseases. 23(11):1908-1915, November 2017.